However, no significant differences were found in serum levels of PSA, testosterone, DHT, LH, and SHBG between the two arms, concluding that in this condition the supplement did not affect the main parameters used to control the progression of prostatic cancer [98]. The gene discussed is SHBG; the disease is prostate carcinoma.